Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504

Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 Bennett, 1999, Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer, J. Pathol., 187, 8, 10.1002/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y Bentwich, 2005, Identification of hundreds of conserved and nonconserved human microRNAs, Nat. Genet., 37, 766, 10.1038/ng1590 Bommer, 2007, p53-mediated activation of miRNA34 candidate tumor-suppressor genes, Curr. Biol., 17, 1298, 10.1016/j.cub.2007.06.068 Bond, 2004, A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans, Cell, 119, 591, 10.1016/j.cell.2004.11.022 Bunz, 1998, Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science, 282, 1497, 10.1126/science.282.5393.1497 Buzzai, 2007, Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth, Cancer Res., 67, 6745, 10.1158/0008-5472.CAN-06-4447 Caldas, 2005, Sizing up miRNAs as cancer genes, Nat. Med., 11, 712, 10.1038/nm0705-712 Calin, 2006, MicroRNA signatures in human cancers, Nat. Rev. Cancer, 6, 857, 10.1038/nrc1997 Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc. Natl. Acad. Sci. USA, 101, 2999, 10.1073/pnas.0307323101 Chen, 1996, mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein, Mol. Cell. Biol., 16, 2445, 10.1128/MCB.16.5.2445 Cimmino, 2005, miR-15 and miR-16 induce apoptosis by targeting BCL2, Proc. Natl. Acad. Sci. USA, 102, 13944, 10.1073/pnas.0506654102 Cummins, 2006, The colorectal microRNAome, Proc. Natl. Acad. Sci. USA, 103, 3687, 10.1073/pnas.0511155103 Deng, 1995, Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control, Cell, 82, 675, 10.1016/0092-8674(95)90039-X Feng, 2007, The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways, Cancer Res., 67, 3043, 10.1158/0008-5472.CAN-06-4149 Feng, 2007, Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations, Proc. Natl. Acad. Sci. USA, 104, 16633, 10.1073/pnas.0708043104 Fukuda, 2000, CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines, Genes Chromosomes Cancer, 29, 315, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1047>3.0.CO;2-E Griffiths-Jones, 2006, miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res., 34, D140, 10.1093/nar/gkj112 Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 He, 2005, A microRNA polycistron as a potential human oncogene, Nature, 435, 828, 10.1038/nature03552 He, 2007, microRNAs join the p53 network—another piece in the tumour-suppression puzzle, Nat. Rev. Cancer, 7, 819, 10.1038/nrc2232 Higuchi, 1988, A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions, Nucleic Acids Res., 16, 7351, 10.1093/nar/16.15.7351 Hu, 2007, A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells, Cancer Res., 67, 2757, 10.1158/0008-5472.CAN-06-2656 Hu, 2007, p53 regulates maternal reproduction through LIF, Nature, 450, 721, 10.1038/nature05993 Kastan, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell, 71, 587, 10.1016/0092-8674(92)90593-2 Kent, 2006, A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes, Oncogene, 25, 6188, 10.1038/sj.onc.1209913 Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev. Cell, 11, 441, 10.1016/j.devcel.2006.09.009 Le, 2009, MicroRNA-125b is a novel negative regulator of p53, Genes Dev., 23, 862, 10.1101/gad.1767609 Levine, 2006, The P53 pathway: what questions remain to be explored?, Cell Death Differ., 13, 1027, 10.1038/sj.cdd.4401910 Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 Lilljebjörn, 2007, Leukemia, 21, 2137, 10.1038/sj.leu.2404879 Lim, 2005, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature, 433, 769, 10.1038/nature03315 Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 Meister, 2004, Mechanisms of gene silencing by double-stranded RNA, Nature, 431, 343, 10.1038/nature02873 Michael, 2003, Reduced accumulation of specific microRNAs in colorectal neoplasia, Mol. Cancer Res., 1, 882 Moran, 2008, Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells, Oncogene, 27, 5567, 10.1038/onc.2008.172 Murphy, 2006, Polymorphic variants in the p53 pathway, Cell Death Differ., 13, 916, 10.1038/sj.cdd.4401907 Nilsson, 2008, An improved method for detecting and delineating genomic regions with altered gene expression in cancer, Genome Biol., 9, R13, 10.1186/gb-2008-9-1-r13 Pillai, 2007, Repression of protein synthesis by miRNAs: how many mechanisms?, Trends Cell Biol., 17, 118, 10.1016/j.tcb.2006.12.007 Plasterk, 2006, Micro RNAs in animal development, Cell, 124, 877, 10.1016/j.cell.2006.02.030 Raver-Shapira, 2007, Transcriptional activation of miR-34a contributes to p53-mediated apoptosis, Mol. Cell, 26, 731, 10.1016/j.molcel.2007.05.017 Renedo, 2001, Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas, Leukemia, 15, 1627, 10.1038/sj.leu.2402248 Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 Vousden, 2009, Blinded by the light: the growing complexity of p53, Cell, 137, 413, 10.1016/j.cell.2009.04.037 Yoon, 2009, PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53, Proc. Natl. Acad. Sci. USA, 106, 7852, 10.1073/pnas.0812148106